Choledocholithiasis

Clinical ascending cholangitis is a high-probability predictor of choledocholithiasis, with reported specificity of 99% to 100%; a stone seen on transabdominal ultrasonography is likewise highly specific (94% to 97%). Either finding supports proceeding to biliary therapy rather than obtaining confirmatory MRCP or EUS solely to establish the diagnosis. ScienceDirectScienceDirectAccuracy of ASGE high-risk criteria in evaluation of patients with suspected common bile duct stones - ScienceDirect

In a patient with suspected choledocholithiasis and clinical cholangitis, prioritize early antibiotic therapy and rapid biliary drainage. ERCP provides both cholangiographic confirmation and endoscopic sphincterotomy with stone extraction or drainage; if endoscopic treatment fails, cholecystectomy with bile duct exploration or intraoperative ERCP is an alternative pathway. easl eu+1easl eu[PDF] EASL Clinical Practice Guidelines on the prevention, diagnosis and ...ScienceDirectManagement of common bile duct stones (choledocholithiasis) and its complications (part 2)

Do not use ERCP as a default diagnostic test in stable patients without a therapeutic indication. Its diagnostic role has been displaced by EUS and MRCP because ERCP is invasive, technically challenging, and can produce serious adverse events even in experienced hands. Wolters KluwerWolters KluwerRole of EUS at high risk for choledocholithiasis... : Endoscopic Ultrasound

The ASGE framework categorizes suspected choledocholithiasis as low risk (<10%), intermediate risk (10% to 50%), or high risk (>50%). The 2019 update emphasizes reducing unnecessary ERCP; low-risk patients proceed to cholecystectomy, intermediate-risk patients receive confirmatory biliary imaging, and high-risk patients proceed to ERCP or another duct-clearance strategy. PubMed+1PubMedASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasisPubMedIntermediate risk of choledocholithiasis: are we on the right path? - PMC

For intermediate-risk patients, choose EUS or MRCP based on local availability, need for same-session endoscopic therapy, contraindications to MRI, and concern for small stones. ASGE suggests either EUS or MRCP for confirmation; systematic-review data indicate broadly comparable diagnostic performance, while EUS may better identify stones smaller than 3 mm. Wolters Kluwer+2Wolters KluwerEndoscopic ultrasonography versus magnetic resonance... : Endoscopic UltrasoundPubMedASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasisPubMedIntermediate risk of choledocholithiasis: are we on the right path? - PMC

Transabdominal ultrasonography remains useful for gallstones, ductal dilation, and directly seen duct stones, but it is substantially less sensitive than MRCP in one direct-comparison study (38% versus 91%) despite 100% specificity. A negative ultrasound therefore does not exclude choledocholithiasis when bilirubin abnormalities, persistent pain, or ductal dilation maintain intermediate clinical probability. ScienceDirectScienceDirectThe diagnostic accuracy of magnetic resonance cholangiopancreatography and ultrasound compared with direct cholangiography in the detection of choledocholithiasis

After a negative MRCP, do not reflexively dismiss a persistent clinical concern. In an intermediate-risk cohort selected for continued pain or abnormal liver enzymes, EUS identified choledocholithiasis in 15% (23 of 153), with ERCP confirmation of sludge or stones in 21 patients; total bilirubin above 3 mg/dL particularly supported considering EUS. Wolters KluwerWolters KluwerEUS assessment for intermediate risk of choledocholithiasis ... : Endoscopic Ultrasound

For confirmed choledocholithiasis, standard endoscopic treatment is ERCP with biliary sphincterotomy and stone extraction using balloon catheters or baskets; more than 90% of common bile duct stones can reportedly be managed by endoscopic sphincterotomy and extraction. Endoscopic papillary balloon dilation is also an emphasized technique in the updated ASGE guidance. NEJM+1NEJMUpdated ASGE Guideline on Management of Choledocholithiasis | NEJM ClinicianWileyRisk factors for biliary tract events during elective cholecystectomy waiting time after endoscopic retrograde cholangiopancreatography for choledocholithiasis - Satoh - 2025 - DEN Open - Wiley Online Library

Laparoscopic common bile duct exploration with cholecystectomy is a valid one-stage alternative where expertise and equipment are available. Compared with ERCP-based management, it avoids post-ERCP pancreatitis but requires advanced laparoscopic skill and can cause bile leakage; the choice should therefore reflect local procedural competence and the anticipated need for definitive gallbladder surgery. BMJ+1BMJSafety and effectiveness of modified laparoscopic transcystic biliary drainage in the treatment of choledocholithiasis: study protocol for a prospective single-arm clinical trialPubMedT-Tube - StatPearls - NCBI Bookshelf

When ductal stones are discovered intraoperatively, clearance can be attempted by transcystic access or direct choledochotomy, with intraoperative contrast cholangiography documenting clearance. Surgical exploration is particularly relevant after failed endoscopic therapy or where a coordinated one-stage surgical approach is available. easl eu+1easl eu[PDF] EASL Clinical Practice Guidelines on the prevention, diagnosis and ...PubMedT-Tube - StatPearls - NCBI Bookshelf

For residual stones detected after cholecystectomy, ERCP with extraction is the reference approach. If ERCP cannot clear the duct, escalate to surgical bile duct exploration or intraoperative ERCP rather than leaving a confirmed obstructing stone untreated. easl eu+1easl eu[PDF] EASL Clinical Practice Guidelines on the prevention, diagnosis and ...ScienceDirectManagement of common bile duct stones (choledocholithiasis) and its complications (part 2)

For patients with simultaneous gallbladder and common bile duct stones who are operative candidates, perform laparoscopic cholecystectomy early after preoperative ERCP—within 72 hours in EASL guidance. This timing is associated with fewer recurrent biliary events than delayed surgery. easl eueasl eu[PDF] EASL Clinical Practice Guidelines on the prevention, diagnosis and ...

Avoid treating placement of a plastic biliary stent as a benign bridge to elective surgery. In a 2025 study of patients awaiting cholecystectomy after ERCP for common bile duct stones, plastic stenting for initial treatment independently increased biliary-tract events during the waiting period (odds ratio 4.25). WileyWileyRisk factors for biliary tract events during elective cholecystectomy waiting time after endoscopic retrograde cholangiopancreatography for choledocholithiasis - Satoh - 2025 - DEN Open - Wiley Online Library

When surgery is not feasible, endoscopic sphincterotomy alone can reduce recurrent biliary pancreatitis but leaves a substantial burden of other biliary events. Across eight case series totaling 320 patients managed with sphincterotomy alone and gallbladder left in situ, recurrent biliary pancreatitis occurred in 1%, but 17% developed biliary symptoms or complications such as cholecystitis or biliary colic. ScienceDirectScienceDirectManagement of gallstone pancreatitis: Cholecystectomy or ERCP and endoscopic sphincterotomy - ScienceDirect

Do not equate a negative CT or ultrasound with ductal clearance in a patient whose clinical probability remains intermediate or high. In a cohort of patients with suspected choledocholithiasis, stones were found at ERCP in 40.6% of intermediate-risk patients and 65.9% of high-risk patients; a negative cross-sectional study should be interpreted alongside the pretest-risk category and ongoing biochemical or clinical evidence of obstruction. ScienceDirectScienceDirectDiagnostic performance of the current risk-stratified approach with computed tomography for suspected choledocholithiasis and its options when negative finding - ScienceDirect

For high-probability patients without cholangitis or a definite stone on cross-sectional imaging, the probability of actual choledocholithiasis may be only slightly above 50%; EUS first can reduce avoidable diagnostic ERCP in the subgroup defined by ductal dilation and bilirubin 1.8 to 4 mg/dL. Wolters KluwerWolters KluwerRole of EUS at high risk for choledocholithiasis... : Endoscopic Ultrasound

After a negative MRCP, persistent abdominal pain or abnormal liver enzymes should trigger reassessment rather than automatic discharge from the duct-stone pathway. EUS can detect small stones that MRCP may miss and produced clinically actionable findings in the selected cohort described above. Wolters Kluwer+1Wolters KluwerEUS assessment for intermediate risk of choledocholithiasis ... : Endoscopic UltrasoundWolters KluwerEndoscopic ultrasonography versus magnetic resonance... : Endoscopic Ultrasound